NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis

Seonmin Lee1,2, Kiichi Nakahira1,3, Jesmond Dalli4

  • 11 Division of Pulmonary and Critical Care Medicine and.

Abstract

Insights

NLRP3 inflammasome deficiency enhances survival in sepsis by promoting the resolution of inflammation and increasing lipoxin B4 (LXB4) production. This suggests targeting NLRP3 could be a therapeutic strategy for sepsis.

Area of Science:

  • Immunology
  • Inflammation research
  • Sepsis pathophysiology

Background:

  • Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection.
  • Excessive inflammation during sepsis can lead to tissue damage and organ failure, despite its role in host defense.
  • Resolution of inflammation, mediated by lipid mediators (LMs), is crucial for restoring homeostasis.

Purpose of the Study:

  • To investigate the role of the nucleotide-binding domain, leucine-rich repeat-containing receptor, pyrin domain-containing-3 (NLRP3) inflammasome in polymicrobial sepsis.
  • To determine how NLRP3 inflammasome activation affects the biosynthesis of lipid mediators (LMs).
  • To explore the therapeutic potential of modulating NLRP3 inflammasome activity and LM production in sepsis.

Main Methods:

  • Cecal ligation and puncture (CLP) model in mice lacking NLRP3 inflammasome-associated molecules to assess mortality and inflammation.
  • Analysis of inflammatory markers in plasma and lavage fluids.
  • Mass spectrometry-based metabololipidomics to quantify local LMs in peritoneal lavage fluid.

Main Results:

  • Genetic deficiency of NLRP3 inflammasome components significantly improved survival in CLP-induced sepsis.
  • NLRP3 deficiency reduced proinflammatory LMs and increased proresolving lipoxin B4 (LXB4) levels.
  • NLRP3 activation led to pyroptosis via caspase-7; caspase-7 deficiency mimicked NLRP3 deficiency effects, and exogenous LXB4 reduced sepsis mortality.

Conclusions:

  • NLRP3 inflammasome deficiency promotes inflammation resolution in polymicrobial sepsis by enhancing LXB4 biosynthesis through a caspase-7-dependent pathway.
  • Increased LXB4 production and reduced proinflammatory cytokines contribute to the enhanced survival observed in NLRP3-deficient septic mice.
  • Targeting the NLRP3 inflammasome and modulating LXB4 biosynthesis represent promising therapeutic strategies for sepsis management.